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Helsinki, FinlandIntroduction: Puumala hantavirus (PUUV) causes a mild type of hemorrhagic fever with renal syndrome
characterized by acute kidney injury (AKI), increased capillary leakage, and thrombocytopenia. Albuminuria
and hematuria in dipstick urine test at hospital admission are known to predict the severity of upcoming AKI.
Methods: We analyzed dipstick urine glucose in 195 patients with acute PUUV infection at hospital
admission, and divided them into 2 categories according to the presence or absence of glucose in the
dipstick urine test. Determinants of disease severity were analyzed in glucosuric and nonglucosuric patients.
Results: Altogether, 24 of 195 patients (12%) had glucosuria. The patients with glucosuria had more severe
AKI than patients without glucosuria (median maximum creatinine concentration 459 mmol/l, range 78–
1041 mmol/l vs. 166 mmol/l, range 51–1499 mmol/l; P < 0.001). The glucosuric patients had more severe
thrombocytopenia (median minimum platelet count 41  109/l, range 5–102  109/l vs. 62  109/l, range 3–
249  109/l; P ¼ 0.006), and more pronounced signs of increased capillary leakage (change in weight,
maximum plasma hematocrit, minimum plasma albumin). The glucosuric patients were more often in
clinical shock at admission (20.8% vs. 1.2%; P < 0.001) and the length of hospital stay was longer (median
7.5 days, range 4–22 days vs. 6 days, range 2–30 days; P ¼ 0.009).
Conclusion: Glucosuria is relatively rare, but when present it predicts a more severe disease course in
patients with acute PUUV infection.
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NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).PUUV, found in Europe and Western Russia, causesa mild type of hemorrhagic fever with renal syn-
drome. An average of 1000 to 3000 serologically
conﬁrmed diagnoses are made annually in Finland, but
up to 5% of blood donors are positive for PUUV an-
tibodies, indicating that most of the cases are mild and
remain undiagnosed.1 The symptoms of the infection
include fever, headache, nausea, abdominal pain,
backache, and visual disturbances. Bleeding diathesis is
rare. The renal involvement includes proteinuria, he-
maturia and AKI. Proteinuria is mainly albuminuria
and can reach nephrotic range; however, the renal
histology is that of acute tubulointerstitial nephritis.2–4
Hospitalized patients often have AKI with transient
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019; published online 31 May 2019oliguria followed by polyuria. Few patients (6%) need
transient dialysis.2 Patients show signs of increased
capillary leakage and are thrombocytopenic. Case fa-
tality is low (<0.1%)5 and ultimate prognosis is good.
Glucosuria is a rather infrequentﬁnding inpatientswith
AKI. In general, glucosuria is detected in diabetic patients
with high serum glucose concentration and in patients
with renal tubular injury such as the Fanconi syndrome.
However, 9% of adults and 12% of children who have
acute PUUV infection present with glucosuria.2,6
We have previously shown that albuminuria and
hematuria in dipstick urine test predict the severity of
upcoming AKI in patients with acute PUUV infec-
tion.7,8 We now report that glucosuria in these patients
is an even stronger predictor of disease severity.MATERIALS AND METHODS
Subjects
The study cohort consisted of 220 adult patients treated
in Tampere University Hospital, Finland, due toKidney International Reports (2019) 4, 1296–1303
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the years 1994 to 2014. A detailed medical history of
the patients was obtained and all patients were care-
fully clinically examined. Clinical features like blood
pressure, heart rate, and weight were measured at least
daily. The daily urine output was followed during the
hospital stay.
One or several previous diagnoses had been made in
7 of 24 patients with glucosuria (29%) and in 50 of 171
patients without glucosuria (30%). The diagnoses were
hypertension (n ¼ 13), coronary heart disease (n ¼ 6),
rheumatoid arthritis (n ¼ 3), bronchial asthma (n ¼ 6),
celiac disease (n ¼ 3), prostate hyperplasia (n ¼ 2),
cerebral infarction (n ¼ 1), juvenile rheumatoid
arthritis (n ¼ 1), Crohn’s disease (n ¼ 1), epilepsy (n ¼
1), and spherocytosis (n ¼ 1). One patient had Henoch-
Schönlein purpura diagnosed 25 years earlier with no
kidney manifestation and 1 patient had a previously
treated kidney tuberculosis. Two of the nonglucosuric
patients had type 2 diabetes. One patient was pregnant
and 1 was breastfeeding. None of the patients in either
group had a known kidney insufﬁciency before the
PUUV infection.
A dipstick urine test was available in 196 patients at
hospital admission. One of them had a previously un-
diagnosed type 2 diabetes with blood glucose level of
26.9 mmol/l at admission and was excluded from
further analyses. The patients were divided into 2
categories based on the presence or absence of glucose
in the dipstick test. Glucosuria was detected in 24 of
195 patients (12.3%), whereas 171 of 195 patients
(87.7%) were negative for glucosuria.
A chest radiograph was taken in 150 patients at
hospital admission. All radiographs were analyzed by a
radiologist.9
All patients provided a written consent and the
study was approved by the Ethics Committee of the
Tampere University Hospital (study codes 97166,
99256, R04180, and R09206).Laboratory Determinations
The diagnosis of PUUV infection in 1982 to 1989 was
based on duplicate samples with 4-fold or grater rise in
IgG titer by the immunoﬂuorescence assay.10 Since
1989, recent PUUV infection was conﬁrmed from a
single serum sample by detecting the typical granular
staining pattern in immunoﬂuorescence assay11 and/or
low avidity of IgG antibodies to PUUV and /or by
detecting PUUV IgM antibodies by an “in-house”
enzyme-linked immunosorbent assay based on a re-
combinant antigen.12 The development and use of these
and other diagnostic methods have been described by
Vaheri et al.13Kidney International Reports (2019) 4, 1296–1303A dipstick urine test was performed in the emer-
gency room at hospital admission and a follow-up
sample was obtained in 11/24 glucosuric and in 76/
171 non-glucosuric patients during the hospital care.
The dipstick urine test was obtained more than once in
4 of 24 glucosuric and 24 of 171 nonglucosuric patients.
Urine dipstick analysis was made by automated tests
based on refractometry using Miditron M (Roche,
Basel, Switzerland) from 1997 onward, Urisys 2400 or
1900 (Roche) from 2004 onward, and Siemens (Munich,
Germany) Clinitek Atlas or Advantus from 2009. The
dipstick assay detects albumin, and it does not react
with immunoglobulins, immunoglobulin light chains,
or tubular proteins. The sensitivity of the assay to
urine albumin is 0.15 to 0.3 g/l (U-Alb 1þ), $ 1 g/l (U-
Alb 2þ) and 3 g/l (U-Alb 3þ). The assay for hematuria
detects heme pseudoperoxidase activity and therefore
it also detects red cell casts and dysmorphic red cells.
The sensitivity of the assay is approximately 10  106
cells/l (approximately 3–5 cells by high-power ﬁeld).
The dipstick test for leukocytes detects granulocyte
and macrophage esterase activity. The sensitivity is
approximately 30  106 cells/l (1–2 cells by high-power
ﬁeld). The dipstick test for glucose detects glucosuria
from glucose level 3 to 5 mmol/l upward. Glucosuria
3þ corresponds to a glucose level exceeding 30 mmol/l.
Plasma creatinine was analyzed by Vitros (Johnson
& Johnson, Rochester, NY) until the 1999 and by Cobas
Integra (F. Hoffmann-La Roche Ltd., Basel, Switzerland)
from thereafter. Plasma creatinine value was deter-
mined daily during the hospital stay and the ﬁrst value
and the highest value (maximum) were taken into the
statistical analysis. In addition, several other blood or
plasma samples were analyzed on a daily basis
including blood cell count, C-reactive protein, and
electrolytes. Plasma creatinine max and blood cell
count were available from all patients. Creatinine ﬁrst
was available from 24 of 24 glucosuric and 167 of 171
nonglucosuric patients. C-reactive protein was avail-
able from 22 of 24 glucosuric and 169 of 171 non-
glucosuric patients. Maximum plasma urea
concentration was available from 20 of 24 of the glu-
cosuric and 85 of 171 nonglucosuric patients and
minimum plasma albumin from 19 of 24 glucosuric and
86 of 171 nonglucosuric patients. Daily urinary volume
was available from all glucosuric and from 163 of 171
nonglucosuric patients. Blood cell count was deter-
mined by automated hematological cell counters (Bayer
Diagnostics, Elkhart, IN), and sodium, potassium, urea,
and albumin concentrations using routine automated
chemistry analyzers. All laboratory determinations
were performed by the Laboratory Centre of the Pir-
kanmaa Hospital District (later named Fimlab labora-
tories), Tampere, Finland. Minimum or maximum of1297
Table 1. Clinical ﬁndings in 195 patients with PUUV infection according to the presence of glucosuria at admission
Glucosuria
n [ 24
No glucosuria
n [ 171
P valueMedian/number Range/% Median/number Range/%
Age 40 25–67 41 21–73 0.908
Men 21 87.5 111 64.5 0.034
BMI 28.1 20.4–37.2 25.6 18.5–41.9 0.031
Shock at admissiona 5 20.8 2 1.2 <0.001
First systolic BP (mm Hg) 115 70–167 124 72–210 0.025
Max systolic BP (mm Hg) 144 123–204 138 95–210 0.016
Max diastolic BP (mm Hg) 94 78–111 87 60–120 0.017
Min systolic BP (mm Hg) 109 60–150 113 68–107 0.243
Min diastolic BP (mm Hg) 75 36–91 70 39–100 0.542
Hospital stay (d) 7.5 4–22 6 2–30 0.009
Weight change (kg)b 4.0 0.5–11.3 2.5 0.1–12.0 0.025
Urinary output min (ml/d) 600 0–4900 1450 0–7000 0.001
Dialysis 3 12.5 7 4.1 0.110
BMI, body mass index; BP, blood pressure; Max, maximum; Min, minimum; PUUV, Puumala hantavirus.
aShock was defined as systolic blood pressure less than 90 mmHg and symptoms of shock.
bDifference between highest and lowest weight during hospital care reflecting both capillary leakage and fluid accumulation during oliguric phase.
Glucosuria: urine dipstick glucose from 1þ to 3þ; No glucosuria: urine dipstick glucose 0.
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indicated in Tables 1 and 2.
Statistical Analysis
For the descriptive analyses, the medians with ranges
and frequencies (n) with percentages and cross-
tabulation were used for the exploratory analyses. For
the comparative analyses, Mann-Whitney U test and
Student’s t-test for independent samples were per-
formed. The c2 tests were used to examine differences
in proportions. The Spearman correlations (rS) were
used to study the relationship between variables. Bi-
nary logistic regression was used to adjust upcoming
severe AKI with plasma creatinine at admission. AllTable 2. Laboratory ﬁndings in 195 patients with PUUV infection accordin
Glucosuria
n [ 24
Median Range
Plasma and blood ﬁndings
Creatinine ﬁrst (mmol/l) 184 72–617
Creatinine max (mmol/l) 459 78–1041
Urea max (mmol/l) 30.3 3.2–39.3
Platelets min ( 109/l) 41 5–102
Hematocrit max 0.51 0.34–0.60
Albumin min (g/l) 24 11–33
Leukocytes max ( 109/l) 16.0 5.7–45
CRP max (mg/l) 81 21–213
Sodium min (mmol/l) 128 122–140
Sodium max (mmol/l) 143 132–159
Potassium min (mmol/l) 3.6 3.7–5.2
Potassium max (mmol/l) 4.4 2.7–4.0
Glucose (mmol/l)a 8.3 4.9–17.6
Urine ﬁndings
Leukocyte count ( 106/l) 4 0–195
Erythrocyte count ( 106/l) 11 2–254
CRP, C-reactive protein; Max, maximum; min, minimum; PUUV, Puumala hantavirus.
aBlood glucose concentration at hospital admission.
Glucosuria: urine dipstick glucose from 1þ to 3þ; No glucosuria: urine dipstick glucose 0.
1298analyses were performed using IBM SPSS Statistics
version 24 (IBM, Armonk, NY).RESULTS
Clinical, Laboratory, and Radiological Findings
Glucosuria was present in 24 of 195 patients (12.3%)
with acute PUUV infection. In most cases, glucosuria
was mild. Twenty patients presented with urine
glucose 1þ in the dipstick test, 3 patients with urine
glucose 2þ, whereas only 1 patient had urine glucose
3þ. Table 1 shows the clinical data of the patients
with and without glucosuria. We found glucosuria in
21 of 132 (15.9%) men but in only 3 of 63 (4.8%)g to the presence of glucosuria at admission
No glucosuria
n [ 171
P valueMedian Range
96 43–1113 0.002
166 51–1499 <0.001
17.4 2.1–54.5 0.012
62 3–249 0.006
0.43 0.33–0.59 <0.001
28 20–39 <0.001
10.2 4.2–35.5 <0.001
77 16–269 0.446
132 109–142 0.001
141 128–150 0.034
3.6 3.3–5.5 0.554
4.3 2.9–4.9 0.306
5.9 3.6–10.9 0.001
3 0–86 0.442
4 0–401 <0.001
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Figure 1. Distribution of ﬁndings in urine dipstick test for hematuria
(U-Eryt) and albuminuria (U-Alb) in patients with acute Puumala
hantavirus infection as classiﬁed to subgroups according to the
presence or absence of glucosuria. Glucosuric patients, n ¼ 24;
nonglucosuric patients, n ¼ 171.
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had a diagnosis of diabetes. Patients who were non-
glucosuric at hospital admission were nonglucosuric
in the follow-up samples. One glucosuric patient was
positive for urine glucose at day 1 after hospital
admission but turned urine glucose negative in the
following samples. The rest of the glucosuric patients
were negative for urine glucose in the follow-up
samples. The patients arrived at the hospital a me-
dian of 4 days after the onset of fever with no dif-
ference between the groups.
The use of drugs potentially inﬂuencing blood
glucose concentration was studied and we found no
differences in the use of beta blockers, thiazide di-
uretics, or corticosteroids (oral or inhaled) or in the use
of antibiotics between the groups (data not shown).
The glucosuric patients were more often in clinical
shock at admission, but presented with higher
maximum systolic and diastolic blood pressure during
the hospital stay, the length of which was also longer
than in nonglucosuric patients, which can be assumed
to reﬂect the overall severity of the disease (Table 1).
There was no difference in smoking habits between the
groups (data not shown).
The laboratory ﬁndings of the patients according to
the presence of glucosuria are presented in Table 2. The
ﬁrst plasma creatinine measured at admission was
higher in glucosuric patients. Patients with glucosuria
had higher maximum plasma creatinine and urea con-
centrations. When adjusted to creatinine at admission,
glucosuria remained a signiﬁcant predictor of severe
AKI, deﬁned as plasma creatinine $ 353.6 mmol/l; odds
ratio 5.9 (95% conﬁdence interval 1.9–18.0).14 The as-
sociation of glucosuria with higher maximum plasma
creatinine level was observed in both sexes (data not
shown). The minimum number of platelets was also
lower in glucosuric patients (Table 2).
The presence of glucosuria was related to variables
reﬂecting capillary leakage. The patients with gluco-
suria had a greater change in weight (Table 1), higher
maximum hematocrit, and lower minimum albumin
(Table 2) when compared with patients without
glucosuria.
Blood glucose sample taken at the hospital admission
was available in 14 of 24 patients with glucosuria and
in 62 of 171 patients without glucosuria. The concen-
tration of blood glucose was higher in the glucosuric
patients (Table 2). Importantly, blood glucose level was
below the kidney glucose threshold of 10 mmol/l in
60/62 nonglucosuric and in 12 of 14 glucosuric pa-
tients. Blood glucose sample taken later during the
hospital care was available in 15 glucosuric and in 84
nonglucosuric patients. The level of blood glucose
decreased and there was no difference in the minimumKidney International Reports (2019) 4, 1296–1303blood glucose concentration between the groups (data
not shown).
There was no correlation between body mass index
(BMI) and blood glucose concentration at hospital
admission either in patients with glucosuria or in pa-
tients without glucosuria (rS ¼ 0.396, P ¼ 0.180 and
rS ¼ 0.178, P ¼ 0.203, respectively). BMI did not
correlate with maximum plasma creatinine value either
in glucosuric (rS ¼ 0.062, P ¼ 0.784) or in non-
glucosuric patients (rS ¼ 0.040, P ¼ 0.623).
The number of urine erythrocytes was higher in
glucosuric patients (Table 2); however, there was no
difference in dipstick hematuria between the groups
(Figure 1). The prevalence and the amount of albumin
in the dipstick urine test at hospital admission was
higher in glucosuric patients. Dipstick albumin was
positive in 96% of patients and reached 3þ in 83% of
patients with glucosuria compared with 83% and 30%
of patients without glucosuria, respectively (P < 0.001
for both) (Figure 1).
The chest radiography was abnormal in 6 of 14
(43%) patients with glucosuria and in 25 of 136 (18%)
patients without glucosuria (P ¼ 0.042). There was no
difference in the occurrence of pleural effusion (data
not shown).
Dipstick Test and the Incidence of AKI
We have previously reported that albuminuria and
hematuria in dipstick urine test predict the severity of
the upcoming AKI.8 Here we evaluated the impact of
dipstick glucosuria, albuminuria, hematuria, and
combined albuminuria þ hematuria þ glucosuria, in
predicting the severity of the upcoming AKI.
When evaluating the impact of glucosuria, the me-
dian maximum creatinine level was higher in patients
with glucosuria than in patients without glucosuria
(459 mmol/l, range 78–1041 vs. 166 mmol/l, range 51–
1499, P < 0.001) (Figure 2a).1299
Figure 2. Maximum plasma creatinine value analyzed according to urine dipstick result: glucosuria (a), albuminuria (b), hematuria (c), and
combined result of albuminuria þ hematuria þ glucosuria (d). The number of patients in each group is indicated in the ﬁgure. Boxplots are with
median, interquartile range, minimum, and maximum within 1.5 interquartile range, and outliers are displayed as circles and extreme values as
asterisks.
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increasing positive result in dipstick urine albumin test
predicted higher maximum creatinine level. The me-
dian maximum creatinine level was 98 mmol/l (range
52–1499) for albumin 0–1þ, 142 mmol/l (range 71–918)
for albumin 2þ, and 372 mmol/l (range 51–1285) for
albumin 3þ (Figure 2b).
When evaluating the impact of hematuria,
increasing positive result in the dipstick test also1300predicted higher maximum creatinine level. The me-
dian for maximum plasma creatinine was 102 mmol/l
(range 58–648) for 0þ; 166 mmol/l (range 52–1499) for
1þ; and 267 mmol/l (range 51–1285) for 2 to 3þ
(Figure 2c).
Finally, higher positive result in the dipstick test for
albuminuria þ hematuria þ glucosuria predicted
higher maximum creatinine. The median maximum
creatinine was 95 mmol/l (range 58–1499) for 0 to 1þ,Kidney International Reports (2019) 4, 1296–1303
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(range 51–1285) for 4 to 5þ, and 585 mmol/l (range 196–
1156) for 6 to 7þ (Figure 2d). There were no patients
with a sum of positive results exceeding 7þ.DISCUSSION
To our knowledge, this is the ﬁrst study to show that
glucosuria predicts the severity of the upcoming AKI
and the overall severity of disease in patients with
acute hantavirus infection. Glucosuria correlated with
higher systolic and diastolic blood pressure during the
hospital stay, which most likely reﬂects the severity of
AKI and ﬂuid retention during the oliguric phase of the
infection. Glucosuria correlated with the determinants
of capillary leakage: low blood pressure at hospital
admission, presence of clinical shock and pathologic
chest radiography changes, high hematocrit, low
plasma albumin, and greater change in weight during
the hospital stay. Glucosuria also correlated with
thrombocytopenia. The length of the hospital stay was
longer in the glucosuric patients, reﬂecting the overall
severity of the disease. Therefore, glucosuria at
admission correlated with all of the main clinical
ﬁndings of severe PUUV infection: AKI, inﬂammation,
capillary leakage, and thrombocytopenia.
In the current study, 12% of the patients presented
with glucosuria at hospital admission. Glucosuria was
more common in men than in women, but the same
relation between glucosuria and more severe AKI was
seen in both sexes. Nonglucosuric patients remained
glucose negative in all follow-up samples. One gluco-
suric patient was glucosuria positive in the ﬁrst follow-
up sample but turned glucosuria negative later during
the hospital care. All the rest of the glucosuric patients
were glucosuria negative in the follow-up urine sam-
ples. It appears that glucosuria is an early and transient
sign in PUUV infection.
Although plasma creatinine was higher in glucosuric
patients already at the time of the ﬁrst creatinine
measurement, it increased more than in nonglucosuric
patients during the hospital care. When the outcome
was severe AKI and the result was adjusted to the ﬁrst
plasma creatinine measured, glucosuria still remained a
signiﬁcant predictor of severe AKI. Therefore, gluco-
suria both associates with and predicts severe AKI. The
patients arrived at hospital a median of 4 days after the
onset of fever and there was no difference between the
groups.
In general, glucosuria most often results from high
blood glucose concentration. Glucose is freely ﬁltered
into primary urine but it is completely reabsorbed in
the tubules. Ninety percent of the reuptake takes place
in the proximal tubule by the sodium-glucoseKidney International Reports (2019) 4, 1296–1303cotransporter type 2/glucose transporter 2 (SGLT2/
GLUT2) (low afﬁnity–high capacity system). The con-
voluted part of the proximal tubule also participates in
glucose reuptake via the SGLT1/GLUT1 (high afﬁnity-
low capacity system). The kidney tubular glucose
threshold for blood glucose is approximately 10 to 11
mmol/l at normal glomerular ﬁltration rate, after which
the reabsorptive capacity is overwhelmed and glucose
appears in the urine.15 When glomerular ﬁltration rate
increases, like in the case of pregnancy, the glucose
threshold level decreases. Conversely, in chronic renal
insufﬁciency, the level of glucose threshold increases
and higher blood glucose levels are tolerated before
glucose appears in the ﬁnal urine. In addition, in dia-
betes, the maximum reabsorptive capacity of the kid-
ney increases and therefore hyperglycemic diabetic
patients may not be glucosuric.15 Little is known about
glucosuria in AKI caused by etiologies other than acute
tubulointerstitial nephritis (TIN).
We found that blood glucose concentration at hos-
pital admission was higher in the glucosuric than in the
nonglucosuric patients. However, none of the gluco-
suric patients had diabetes. Also, there was no differ-
ence in the use of drugs that can inﬂuence blood
glucose concentration. During the hospital stay, the
blood glucose levels decreased and there was no dif-
ference in the minimum blood glucose concentration
between the groups. Further, at admission, the median
blood glucose level in the glucosuric patients was 8.3
mmol /l, which is below the threshold level of a healthy
kidney and should not result in glucosuria. It appears
that glucosuria detected in the present study was
caused by kidney damage and not by hyperglycemia.
This is in line with the results obtained in animal
studies in which glycerol-induced acute renal failure
and proximal tubular damage resulted in glucosuria in
normoglycemic rats.16
In the present study, BMI was higher in glucosuric
patients but BMI did not correlate with either blood
glucose level at hospital admission or maximum plasma
creatinine value. Therefore, BMI does not explain the
glucosuria or the observed association between gluco-
suria and severe AKI. It is possible that the higher
blood glucose concentration in the glucosuric patients
was due to the hypercortisolism caused by the acute
PUUV infection,17 and that cortisol raised blood
glucose more in the obese patients. However, cortisol
metabolism was not systematically analyzed in this
study.
Glucosuria can result from proximal tubular damage,
such as the Fanconi syndrome. PUUV is known to
infect tubular epithelial cells and histologically PUUV
infection causes an acute TIN.4 In adult patients, 60%
to 80% of TIN cases are drug induced, the second most1301
CLINICAL RESEARCH J Tietäväinen et al.: Glucosuria in Hantavirus Infectioncommon cause being autoimmune diseases.18 However,
glucosuria is not a common ﬁnding in acute TIN in
adults. Some causative agents are more likely than
others to induce glucosuria in acute TIN. Among these
are some non–b-lactam antibiotics, antiviral agents,
cytostats, the antiepileptic sodium valproate, and the
mood stabilizer lithium.19,20 In addition, D-serine, a
newly acknowledged uremic toxin, can cause damage
to the proximal tubule and glucosuria.21 As a com-
parison, 100% of pediatric patients with TIN and
uveitis syndrome had glucosuria.22 The etiology of TIN
and uveitis syndrome, remains unknown.
Several infections can cause TIN. In pediatric pa-
tients with Yersinia pseudotuberculosis–induced
interstitial nephritis, 27% of patients with AKI
exhibited glucosuria, whereas none of the patients with
normal kidney function had glucosuria.23 In a small
case series from the Czech Republic, all 3 pediatric
patients with PUUV infection had glucosuria and
AKI.24 In our previous reports from patients with acute
PUUV infection, 9% of adults and 12% of children had
glucosuria.2,6 However, to our knowledge, this is the
ﬁrst time glucosuria has been used as a maker of disease
severity in infection-induced AKI.
The PUUV typically infects kidney tubular epithelial
cells. The PUUV RNA is mostly seen in the distal
tubuli25 and several adhesion molecules and cytokines
are seen in the peritubular area of the distal nephron.26
Subsequent splitting of the tubular basement mem-
brane has been detected in both proximal and distal
tubuli.27 The proximal tubule is essential in the reup-
take of glucose. In addition, inﬂammation and cytokine
release inﬂuence kidney function by decreasing renal
tissue perfusion and glomerular ﬁltration rate,
decreasing the expression of SGLT2, SGLT3, and GLUT
2, and increasing fractional glucose excretion.28 Several
different cytokines are also known to inﬂuence the
severity of PUUV infection.29–31 As in a case of glu-
cosuria in experimental animal study,16 glucosuria in
our study is most likely a marker of a more severe
tubular injury in patients with PUUV infection.
Whether glucosuria is a marker of unspeciﬁc damage to
the proximal tubular cells or a result of a speciﬁc pa-
thology needs further investigation.
The prevalence and the amount of albuminuria were
higher in patients with glucosuria than in patients
without glucosuria (Figure 1). Although urine dipstick
hematuria did not differ between the study groups, the
number of urine erythrocytes was higher in the glu-
cosuric patients (Table 2). The reason for this discrep-
ancy is unknown.
We previously reported that albuminuria, hematu-
ria, and combined albuminuria þ hematuria predicted
the severity of the upcoming AKI.7,8 We now evaluated1302how different variables or combination of variables in
the dipstick urine test predict AKI. Glucosuria is rare,
but the presence of even mild glucosuria associates and
predicts AKI (Figure 2a). Albuminuria and hematuria
are more common and they have a dose-dependent
effect on the severity of AKI. Mild albuminuria and
mild hematuria indicate benign disease course, whereas
abundant albuminuria and hematuria predict severity
of AKI (Figure 2b and c); however, the maximum
creatinine even with abundant albuminuria or hema-
turia is still lower than in glucosuric patients. In the
combination of albuminuria, hematuria, and gluco-
suria, there appears to be a threshold level of 4þ
(Figure 2d), which separates patients at greater risk of
developing severe AKI.
Glucosuria, as well as albuminuria and hematuria,
predict the overall severity of the infection. It is of
interest, however, that only glucosuria associates with
the level of thrombocytopenia.
In conclusion, we show here for the ﬁrst time that
glucosuria in patients with acute hantavirus infection
is a good marker for the severity of upcoming AKI and
the overall course of the PUUV infection.
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